Patents by Inventor Carine Maggetto

Carine Maggetto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120077268
    Abstract: The present invention relates to a process for culturing animal cells, e.g., human, diploid anchorage-dependent cells, in the absence of exogenous components of primary animal origin. In particular, the invention provides cell culture media substantially free of exogenous components of primary and secondary animal origin which comprises at least one, more preferably several, exogenous animal-free growth factors. The present invention also relates to a process for cultivating animal cells using a protease of non-animal origin for passaging cells.
    Type: Application
    Filed: October 10, 2011
    Publication date: March 29, 2012
    Applicant: GlaxoSmithKline Biologicals, s.a.
    Inventors: Brigitte Ghislaine Louise Aerts, Yves Jules Maurice Ghislain, Marie-Monique Jane Gonze, Isabelle Solange Lucie Knott, Carine Maggetto
  • Patent number: 8034617
    Abstract: The present invention relates to a process for animal, preferably human, diploid anchorage-dependent cell culture, in the absence of exogenous components of primary animal origin, and to a cell culture medium substantially free of exogenous components of primary animal origin suitable for carrying out said process. In particular the invention concerns a cell culture medium which comprises at least one, more preferably several, exogenous animal-free growth factors. The present invention also relates to a process for cultivating animal, preferably human diploid anchorage-dependent cells in a medium according to the invention, involving the use of a trypsin substitute of non-animal origin for passaging cells. The invention further relates to a process for producing viruses, viral vaccines and the like.
    Type: Grant
    Filed: March 1, 2004
    Date of Patent: October 11, 2011
    Assignee: Glaxosmithkline Biologicals S.A.
    Inventors: Brigitte Ghislaine Louise Aerts, Yves Jules Maurice Ghislain, Marie-Monique Jane Gonze, Isabelle Solange Lucie Knott, Carine Maggetto
  • Publication number: 20060183224
    Abstract: The present invention relates to a process for animal, preferably human, diploid anchorage-dependent cell culture, in the absence of exogenous components of primary animal origin, and to a cell culture medium substantially free of exogenous components of primary animal origin suitable for carrying out said process. In particular the invention concerns a cell culture medium which comprises at least one, more preferably several, exogenous animal-free growth factors. The present invention also relates to a process for cultivating animal, preferably human diploid anchorage-dependent cells in a medium according to the invention, involving the use of a trypsin substitute of non-animal origin for passaging cells. The invention further relates to a process for producing viruses, viral vaccines and the like.
    Type: Application
    Filed: March 1, 2004
    Publication date: August 17, 2006
    Inventors: Brigitte Aerts, Yves Jules Ghislain, Marie-Monique Gonze, Isabelle Solange Knott, Carine Maggetto